Cargando…

Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas

BACKGROUND: Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it. OBJECTIVE: We sought to examine the return on investment, in terms of reduced costs attributed to cancer prevention, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsak, Gabriela, Miller, Anastasia, Allen, Carlton M., Singh, Karan P., McGaha, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018884/
https://www.ncbi.nlm.nih.gov/pubmed/31123931
http://dx.doi.org/10.1007/s41669-019-0147-y
_version_ 1783497412258562048
author Orsak, Gabriela
Miller, Anastasia
Allen, Carlton M.
Singh, Karan P.
McGaha, Paul
author_facet Orsak, Gabriela
Miller, Anastasia
Allen, Carlton M.
Singh, Karan P.
McGaha, Paul
author_sort Orsak, Gabriela
collection PubMed
description BACKGROUND: Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it. OBJECTIVE: We sought to examine the return on investment, in terms of reduced costs attributed to cancer prevention, of a CRC screening outreach program providing education and screening in a primarily rural region targeting the uninsured and underinsured. METHODS: The expenditures of the Northeast Texas CRC screening program were calculated for the years of 2016 and 2017. Prices ($US) were adjusted for inflation and converted to year 2017 values. The costs saved were calculated using the estimated costs of CRC care present in the literature. RESULTS: For fiscal years 2016 and 2017, the program provided an average return of $US1.46–2.06 for every tax dollar spent. Estimated cost avoidance was $US165,080 per avoided case and estimated cost avoidance of $US245,601 among early-stage cancer cases detected, resulting in potential savings ranging from $US3,893,676 to $US4,837,923. CONCLUSION: A CRC outreach program providing education and screening operating in less densely populated regions yields a positive return on investment.
format Online
Article
Text
id pubmed-7018884
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-70188842020-02-28 Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas Orsak, Gabriela Miller, Anastasia Allen, Carlton M. Singh, Karan P. McGaha, Paul Pharmacoecon Open Original Research Article BACKGROUND: Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it. OBJECTIVE: We sought to examine the return on investment, in terms of reduced costs attributed to cancer prevention, of a CRC screening outreach program providing education and screening in a primarily rural region targeting the uninsured and underinsured. METHODS: The expenditures of the Northeast Texas CRC screening program were calculated for the years of 2016 and 2017. Prices ($US) were adjusted for inflation and converted to year 2017 values. The costs saved were calculated using the estimated costs of CRC care present in the literature. RESULTS: For fiscal years 2016 and 2017, the program provided an average return of $US1.46–2.06 for every tax dollar spent. Estimated cost avoidance was $US165,080 per avoided case and estimated cost avoidance of $US245,601 among early-stage cancer cases detected, resulting in potential savings ranging from $US3,893,676 to $US4,837,923. CONCLUSION: A CRC outreach program providing education and screening operating in less densely populated regions yields a positive return on investment. Springer International Publishing 2019-05-23 /pmc/articles/PMC7018884/ /pubmed/31123931 http://dx.doi.org/10.1007/s41669-019-0147-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
Orsak, Gabriela
Miller, Anastasia
Allen, Carlton M.
Singh, Karan P.
McGaha, Paul
Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas
title Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas
title_full Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas
title_fullStr Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas
title_full_unstemmed Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas
title_short Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas
title_sort return on investment of free colorectal cancer screening tests in a primarily rural uninsured or underinsured population in northeast texas
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018884/
https://www.ncbi.nlm.nih.gov/pubmed/31123931
http://dx.doi.org/10.1007/s41669-019-0147-y
work_keys_str_mv AT orsakgabriela returnoninvestmentoffreecolorectalcancerscreeningtestsinaprimarilyruraluninsuredorunderinsuredpopulationinnortheasttexas
AT milleranastasia returnoninvestmentoffreecolorectalcancerscreeningtestsinaprimarilyruraluninsuredorunderinsuredpopulationinnortheasttexas
AT allencarltonm returnoninvestmentoffreecolorectalcancerscreeningtestsinaprimarilyruraluninsuredorunderinsuredpopulationinnortheasttexas
AT singhkaranp returnoninvestmentoffreecolorectalcancerscreeningtestsinaprimarilyruraluninsuredorunderinsuredpopulationinnortheasttexas
AT mcgahapaul returnoninvestmentoffreecolorectalcancerscreeningtestsinaprimarilyruraluninsuredorunderinsuredpopulationinnortheasttexas